Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170390 · ClinicalTrials.gov registry record · Phase 4
Oral Contraceptives and Body Mass Index
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT01170390 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 32 participants.
The verdict
NCT01170390, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
The main hypothesis for this study is that increased Body Mass Index (BMI) alters oral contraceptive metabolism in a manner which results in decreased effectiveness in obese women.
Interventions
- DRUG All participants (Aviane)
- DRUG Portia
- DRUG Aviane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01170390
The ClinicalTrials.gov registry entry for NCT01170390 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which All participants (Aviane) is the first listed.
NCT01170390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01170390 about?
NCT01170390 is a clinical study titled "Oral Contraceptives and Body Mass Index". The main hypothesis for this study is that increased Body Mass Index (BMI) alters oral contraceptive metabolism in a manner which results in decreased effectiveness in obese women.
What is the current status of trial NCT01170390?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2009-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01170390?
The interventions under investigation include: All participants (Aviane) (DRUG), Portia (DRUG), Aviane (DRUG).
Who is sponsoring clinical trial NCT01170390?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.